Cardiovascular Manifestations in Behçet's Disease - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/39193757/
Cardiovascular involvement in Behçet's disease (BD) is considerably related to morbidity and mortality. However, the cardiovascular manifestation is sometimes difficult to distinguish from those of other causes. The suspicion of...
M6A modification in cardiovascular disease: With a focus on programmed cell death - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/38988324/
N 6 -methyladenosine (m 6 A) methylation is one of the most predominant internal RNA modifications in eukaryotes and has become a hot spot in the field of epigenetics in...
m6A methylation, a prevalent RNA modification, plays a crucial role in programmed cell death (PCD) and cardiovascular diseases (CVDs), offering promising therapeutic strategies for preventing and treating CVDs.
Treating Cardiovascular Disease in the Inflammatory Setting of Rheumatoid Arthritis: An Ongoing Challenge - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/39062180/
Despite progress in treating rheumatoid arthritis, this autoimmune disorder confers an increased risk of developing cardiovascular disease (CVD). Widely used screening protocols and current clinical guidelines are inadequate for the...
Rheumatoid arthritis heightens cardiovascular disease risk through shared inflammatory pathways, necessitating improved screening, tailored treatments, and further research into risk assessment tools and novel immunotherapeutics.
New Modifiable Risk Factors Influencing Coronary Artery Disease Severity
Source : https://pubmed.ncbi.nlm.nih.gov/39063008/
Cardiovascular diseases (CVDs) remain the leading cause of death worldwide with coronary artery disease (CAD) being the first culprit in this group. In terms of CAD, not only its presence...
Integrating novel risk factors with traditional ones in CAD severity assessment can enhance secondary prevention and reduce coronary atherosclerosis progression.
Hegemony of inflammation in atherosclerosis and coronary artery disease
Source : https://pubmed.ncbi.nlm.nih.gov/38242225/
Inflammation drives coronary artery disease and atherosclerosis implications. Lipoprotein entry, retention, and oxidative modification cause endothelial damage, triggering innate and adaptive immune responses. Recruited immune cells orchestrate the early atherosclerotic...
Inflammation plays a crucial role in CAD development, making targeted anti-inflammatory therapies vital for managing atherosclerosis and reducing cardiovascular events.